RETRACTION: MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo

撤稿:MCCK1增强替莫唑胺的抗癌作用,可减弱胶质母细胞瘤细胞在体外和体内的侵袭、迁移和上皮-间质转化。

阅读:1

Abstract

Retraction: T. Liu, A. Li, Y. Xu, and Y. Xin, "MCCK1 Enhances the Anticancer Effect of Temozolomide in Attenuating the Invasion, Migration and Epithelial-Mesenchymal Transition of Glioblastoma Cells in Vitro and in Vivo," Cancer Medicine 8, no. 2 (2019): 751-760. https://doi.org/10.1002/cam4.1951. The above article, published online on 18 January 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Stephen Tait, and John Wiley & Sons Ltd. A report submitted by a third party noted image duplications with other articles by different author groups. Specifically, the report found image duplications with other published articles in Figures 1E, 2B, 3A, 3D and 4C. The report also found image overlap between images in Figure 3A. The retraction has been agreed to because the evidence of image duplication across different articles, each of which describes different experimental conditions, fundamentally compromises the editors' confidence in the conclusions presented. The authors have voluntarily agreed with the retraction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。